USD
$0.00
(0.00%
)At Close (As of Sep 5, 2025)
$2.09B
Market Cap
3.189
P/E Ratio
11.29
EPS
$62.58
52 Week High
$23.41
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $32M |
Total Revenue | $36M |
Cost Of Revenue | $4.2M |
Costof Goods And Services Sold | $4.2M |
Operating Income | -$426M |
Selling General And Administrative | $157M |
Research And Development | $301M |
Operating Expenses | $458M |
Investment Income Net | - |
Net Interest Income | $48M |
Interest Income | $48M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $5.7M |
Income Before Tax | $718M |
Income Tax Expense | $44M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $674M |
Comprehensive Income Net Of Tax | - |
Ebit | -$431M |
Ebitda | -$426M |
Net Income | $674M |
Field | Value (USD) |
---|---|
Total Assets | $1.7B |
Total Current Assets | $966M |
Cash And Cash Equivalents At Carrying Value | $76M |
Cash And Short Term Investments | $76M |
Inventory | $28M |
Current Net Receivables | $4.1M |
Total Non Current Assets | $698M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | $638M |
Short Term Investments | $817M |
Other Current Assets | $40M |
Other Non Current Assets | - |
Total Liabilities | $122M |
Total Current Liabilities | $81M |
Current Accounts Payable | $17M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $17M |
Total Non Current Liabilities | $41M |
Capital Lease Obligations | $57M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $57M |
Other Current Liabilities | $47M |
Other Non Current Liabilities | $880K |
Total Shareholder Equity | $1.5B |
Treasury Stock | - |
Retained Earnings | -$149M |
Common Stock | $73K |
Common Stock Shares Outstanding | $58M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$390M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $5.7M |
Capital Expenditures | $1.7M |
Change In Receivables | - |
Change In Inventory | -$8.5M |
Profit Loss | - |
Cashflow From Investment | $363M |
Cashflow From Financing | $14M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $674M |
Field | Value (USD) |
---|---|
Gross Profit | $32M |
Total Revenue | $36M |
Cost Of Revenue | $4.2M |
Costof Goods And Services Sold | $4.2M |
Operating Income | -$426M |
Selling General And Administrative | $157M |
Research And Development | $301M |
Operating Expenses | $458M |
Investment Income Net | - |
Net Interest Income | $48M |
Interest Income | $48M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $5.7M |
Income Before Tax | $718M |
Income Tax Expense | $44M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $674M |
Comprehensive Income Net Of Tax | - |
Ebit | -$431M |
Ebitda | -$426M |
Net Income | $674M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts.